Literature DB >> 21920268

Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.

Jia-Yi Dong1, Yong-Hong Zhang, Li-Qiang Qin.   

Abstract

OBJECTIVES: Our goal was to evaluate the association between erectile dysfunction (ED) and risk of cardiovascular disease (CVD) and all-cause mortality by conducting a meta-analysis of prospective cohort studies.
BACKGROUND: Observational studies suggest an association between ED and the incidence of CVD. However, whether ED is an independent risk factor of CVD remains controversial.
METHODS: The PubMed database was searched through January 2011 to identify studies that met pre-stated inclusion criteria. Reference lists of retrieved articles were also reviewed. Two authors independently extracted information on the designs of the studies, the characteristics of the study participants, exposure and outcome assessments, and control for potential confounding factors. Either a fixed- or a random-effects model was used to calculate the overall combined risk estimates.
RESULTS: Twelve prospective cohort studies involving 36,744 participants were included in the meta-analysis. The overall combined relative risks for men with ED compared with the reference group were 1.48 (95% confidence interval [CI]: 1.25 to 1.74) for CVD, 1.46 (95% CI: 1.31 to 1.63) for coronary heart disease, 1.35 (95% CI: 1.19 to 1.54) for stroke, and 1.19 (95% CI: 1.05 to 1.34) for all-cause mortality. Sensitivity analysis restricted to studies with control for conventional cardiovascular risk factors yielded similar results. No evidence of publication bias was observed.
CONCLUSIONS: This meta-analysis of prospective cohort studies suggests that ED significantly increases the risk of CVD, coronary heart disease, stroke, and all-cause mortality, and the increase is probably independent of conventional cardiovascular risk factors.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21920268     DOI: 10.1016/j.jacc.2011.06.024

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  111 in total

1.  Significant improvement of erectile function after Roux-en-Y gastric bypass surgery in obese Chinese men with erectile dysfunction.

Authors:  Li Kun; Zhang Pin; Di Jianzhong; Han Xiaodong; Yu Haoyong; Bao Yuqian; Zhang Hongwei
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

2.  Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.

Authors:  Alexander W Pastuszak; Daniel A Hyman; Naveen Yadav; Guilherme Godoy; Larry I Lipshultz; Andre B Araujo; Mohit Khera
Journal:  J Sex Med       Date:  2015-03-02       Impact factor: 3.802

3.  Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study.

Authors:  Zeki Bayraktar; Selami Albayrak
Journal:  Int Urol Nephrol       Date:  2019-06-22       Impact factor: 2.370

Review 4.  Sexual counselling for sexual problems in patients with cardiovascular disease.

Authors:  Molly Byrne; Sally Doherty; Bengt G A Fridlund; Jan Mårtensson; Elaine E Steinke; Tiny Jaarsma; Declan Devane
Journal:  Cochrane Database Syst Rev       Date:  2016-02-24

5.  Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses.

Authors:  Martin Reriani; Andreas J Flammer; Jing Li; Megha Prasad; Charanjit Rihal; Abhiram Prasad; Ryan Lennon; Lilach O Lerman; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-11       Impact factor: 1.439

6.  Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study.

Authors:  M Karabakan; A Bozkurt; S Akdemir; M Gunay; E Keskin
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

7.  Endovascular therapy for vasculogenic erectile dysfunction.

Authors:  Jason H Rogers; Krishna J Rocha-Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

8.  The expanding sphere of primary prevention for coronary artery disease in persons with erectile dysfunction.

Authors:  Abraham Samuel Babu; Abraham Sunderlal Babu
Journal:  Oman Med J       Date:  2012-05

Review 9.  Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies.

Authors:  Yu Fan; Binbin Hu; Changfeng Man; Feilun Cui
Journal:  World J Urol       Date:  2018-05-03       Impact factor: 4.226

10.  Uric acid level and erectile dysfunction in patients with coronary artery disease.

Authors:  Yalcin Solak; Hakan Akilli; Mehmet Kayrak; Alpay Aribas; Abduzhappar Gaipov; Suleyman Turk; Santos E Perez-Pozo; Adrian Covic; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Sex Med       Date:  2013-09-25       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.